Dengue in Pune city, India (2017-2019): a comprehensive analysis

Front Public Health. 2024 Sep 20:12:1354510. doi: 10.3389/fpubh.2024.1354510. eCollection 2024.

Abstract

Objectives: To understand the dynamics of dengue disease with special reference to (1) age (2) primary/secondary infections (3) serostatus and (4) serotypes examined during three consecutive years.

Methods: During 3 dengue seasons (2017-19), NS1/IgM ELISAs were used for dengue diagnosis in one of the 15 administrative wards of Pune City, India. Predefined symptoms were recorded at the time of diagnosis/hospitalization. IgG-capture ELISA (Panbio) was used to differentiate primary/secondary infections. DENV serotypes were determined for 260 viral RNA-positive patients.

Results: During the 3 years, 3,014/6,786 (44.4%, 41.4-49.9%) suspected cases were diagnosed as dengue. Use of either NS1 or IgM would have missed 25.5% or 43% of the confirmed dengue cases, respectively. Notably, a higher proportion of secondary dengue cases remained mild while a substantial proportion of primary infections developed warning signs. The symptoms among Dengue/non-dengue patients and primary/secondary infections varied and influenced by age and serostatus. The number and proportion of dengue serotypes varied yearly. A remarkable decline in dengue cases was observed during the COVID-19 pandemic years.

Conclusion: A substantial proportion of primary and secondary dengue patients progress to warning signs/severity or mild infection respectively, underscoring the possible role of non-ADE mechanisms in causing severe dengue that requires hospitalization. Both NS1 and IgM should be used for efficient diagnosis.

Keywords: DENV; India; dengue; disease category; primary dengue; secondary dengue; symptoms.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Viral / blood
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology
  • Child
  • Child, Preschool
  • Dengue Virus* / isolation & purification
  • Dengue* / diagnosis
  • Dengue* / epidemiology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunoglobulin M / blood
  • India / epidemiology
  • Infant
  • Male
  • Middle Aged
  • Serogroup
  • Young Adult

Substances

  • Immunoglobulin M
  • Antibodies, Viral

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Indian Council for Medical Research (ICMR, http://www.icmr.nic.in/), grant number, ECD/NTF/8/2016-17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.